Royal Philips Electronics reported that it will lead a new European Union (EU)-funded research project aimed at improving care of heart patients through the development of telemonitoring solutions.
The HeartCycle project will start on March 1, and will be a large biomedical and healthcare research project within the EU.
The HeartCycle consortium will work to improve the quality of care for coronary heart disease and heart failure patients by developing systems for monitoring their condition at home and involving them in the daily management of their disease, Philips said. The systems will comprise unobtrusive sensors built into the patient’s clothing or bed sheets and home appliances, such as weight scales and blood pressure monitors.
Philips said the consortium aims to develop dedicated software that analyzes the acquired data, and can be programmed to provide feedback on the patient’s health status, plus their adherence to prescribed therapies and progress towards achieving health status markers. The company said it also aims to develop mechanisms to report data back to clinicians automatically, so that they can prescribe personalized therapies and lifestyle advice.
The public and private partners from 18 research, academic, industrial and medical organizations from nine different European countries and China will team up in the project, the company said.
HeartCycle will run for four years and has a budget of approximately €21 million ($31.9 million), of which approximately €14 million ($21 million) will be funded by the European Union as part of the EU 7th Framework Program.